Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations (PREVAC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05075941 |
Recruitment Status :
Not yet recruiting
First Posted : October 13, 2021
Last Update Posted : October 19, 2021
|
Sponsor:
Epicentre
Collaborators:
Institut de Recherche en Santé Publique, France
Medecins Sans Frontieres, Netherlands
Médecins du Monde
CROIX ROUGE FRANCAISE
OBSERVATOIRE DU SAMU SOCIAL
INTERLOGEMENT 93
Agence Regionale de Sante d'Ile de France
Information provided by (Responsible Party):
Epicentre
Tracking Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
First Submitted Date | October 7, 2021 | ||||||||||||||
First Posted Date | October 13, 2021 | ||||||||||||||
Last Update Posted Date | October 19, 2021 | ||||||||||||||
Estimated Study Start Date | November 2021 | ||||||||||||||
Estimated Primary Completion Date | December 2021 (Final data collection date for primary outcome measure) | ||||||||||||||
Current Primary Outcome Measures |
|
||||||||||||||
Original Primary Outcome Measures | Same as current | ||||||||||||||
Change History | |||||||||||||||
Current Secondary Outcome Measures | Not Provided | ||||||||||||||
Original Secondary Outcome Measures | Not Provided | ||||||||||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||||||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||||||||||
Descriptive Information | |||||||||||||||
Brief Title | Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations | ||||||||||||||
Official Title | PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 | ||||||||||||||
Brief Summary | The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are :
|
||||||||||||||
Detailed Description | Not Provided | ||||||||||||||
Study Type | Observational | ||||||||||||||
Study Design | Observational Model: Other Time Perspective: Cross-Sectional |
||||||||||||||
Target Follow-Up Duration | Not Provided | ||||||||||||||
Biospecimen | Not Provided | ||||||||||||||
Sampling Method | Non-Probability Sample | ||||||||||||||
Study Population | migrants, homeless and travelling community | ||||||||||||||
Condition | COVID-19 | ||||||||||||||
Intervention | Other: Vaccination coverage
proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population
|
||||||||||||||
Study Groups/Cohorts |
|
||||||||||||||
Publications * | Not Provided | ||||||||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||||||||
Recruitment Information | |||||||||||||||
Recruitment Status | Not yet recruiting | ||||||||||||||
Estimated Enrollment |
3470 | ||||||||||||||
Original Estimated Enrollment | Same as current | ||||||||||||||
Estimated Study Completion Date | February 2022 | ||||||||||||||
Estimated Primary Completion Date | December 2021 (Final data collection date for primary outcome measure) | ||||||||||||||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
||||||||||||||
Sex/Gender |
|
||||||||||||||
Ages | 18 Years and older (Adult, Older Adult) | ||||||||||||||
Accepts Healthy Volunteers | Not Provided | ||||||||||||||
Contacts |
|
||||||||||||||
Listed Location Countries | Not Provided | ||||||||||||||
Removed Location Countries | |||||||||||||||
Administrative Information | |||||||||||||||
NCT Number | NCT05075941 | ||||||||||||||
Other Study ID Numbers | 2021-A01960-41 | ||||||||||||||
Has Data Monitoring Committee | No | ||||||||||||||
U.S. FDA-regulated Product |
|
||||||||||||||
IPD Sharing Statement |
|
||||||||||||||
Current Responsible Party | Epicentre | ||||||||||||||
Original Responsible Party | Same as current | ||||||||||||||
Current Study Sponsor | Epicentre | ||||||||||||||
Original Study Sponsor | Same as current | ||||||||||||||
Collaborators |
|
||||||||||||||
Investigators |
|
||||||||||||||
PRS Account | Epicentre | ||||||||||||||
Verification Date | October 2021 |